atherogenic dyslipidemia
Lipid disorder characterized by elevated triglycerides, low HDL cholesterol, and increased small dense LDL particles.
Full Definition
Atherogenic dyslipidemia is a specific pattern of lipid abnormalities that significantly increases cardiovascular risk beyond what would be predicted by LDL cholesterol alone. This condition is characterized by elevated triglycerides (typically >150 mg/dL), low HDL cholesterol, and a predominance of small, dense LDL particles that are more likely to penetrate the arterial wall. It is commonly associated with insulin resistance, metabolic syndrome, and type 2 diabetes. Recognition of this pattern is crucial for appropriate risk assessment and targeted therapy in preventive cardiology.
Usage
Usage note: Distinguish from general dyslipidemia by specifying the triad of abnormalities.
In Context
- "The patient's atherogenic dyslipidemia pattern suggested underlying insulin resistance." — lipid clinic consultation
- "Treatment of atherogenic dyslipidemia requires addressing both triglycerides and HDL levels." — treatment plan documentation